{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:58:05Z","timestamp":1760623085563,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008660","name":"Kurozumi Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008660","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tokyo Hokenkai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10096-018-3437-x","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T13:10:57Z","timestamp":1544793057000},"page":"373-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-5057","authenticated-orcid":false,"given":"Takashi","family":"Hirama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Brode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore K.","family":"Marras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"3437_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","volume":"36","author":"DR Prevots","year":"2015","unstructured":"Prevots DR, Marras TK (2015) Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 36:13\u201334. \n                    https:\/\/doi.org\/10.1016\/j.ccm.2014.10.002","journal-title":"Clin Chest Med"},{"key":"3437_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.3201\/eid1911.130737","volume":"19","author":"TK Marras","year":"2013","unstructured":"Marras TK, Mendelson D, Marchand-Austin A et al (2013) Pulmonary nontuberculous mycobacterial disease, Ontario, Canada, 1998-2010. Emerg Infect Dis 19:1889\u20131891. \n                    https:\/\/doi.org\/10.3201\/eid1911.130737","journal-title":"Emerg Infect Dis"},{"key":"3437_CR3","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1183\/09031936.00149212","volume":"42","author":"W Hoefsloot","year":"2013","unstructured":"Hoefsloot W, Van Ingen J, Andrejak C et al (2013) The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 42:1604\u20131613. \n                    https:\/\/doi.org\/10.1183\/09031936.00149212","journal-title":"Eur Respir J"},{"key":"3437_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3201\/eid1403.061393","volume":"14","author":"J Ingen van","year":"2008","unstructured":"van Ingen J, Boeree MJ, de Lange WCM et al (2008) Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 14:385\u2013389. \n                    https:\/\/doi.org\/10.3201\/eid1403.061393","journal-title":"Emerg Infect Dis"},{"key":"3437_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/thx.2008.096842","volume":"64","author":"C Andrejak","year":"2009","unstructured":"Andrejak C, Lescure F-X, Pukenyte E et al (2009) Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 64:291\u2013296. \n                    https:\/\/doi.org\/10.1136\/thx.2008.096842","journal-title":"Thorax"},{"key":"3437_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367\u2013416. \n                    https:\/\/doi.org\/10.1164\/rccm.200604-571ST","journal-title":"Am J Respir Crit Care Med"},{"key":"3437_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","volume":"185","author":"M Hayashi","year":"2012","unstructured":"Hayashi M, Takayanagi N, Kanauchi T et al (2012) Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 185:575\u2013583. \n                    https:\/\/doi.org\/10.1164\/rccm.201107-1203OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3437_CR8","doi-asserted-by":"publisher","first-page":"408","DOI":"10.5588\/ijtld.11.0148","volume":"16","author":"Y Ito","year":"2012","unstructured":"Ito Y, Hirai T, Maekawa K et al (2012) Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis 16:408\u2013414. \n                    https:\/\/doi.org\/10.5588\/ijtld.11.0148","journal-title":"Int J Tuberc Lung Dis"},{"key":"3437_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00408-018-0087-9","volume":"196","author":"T Hirama","year":"2018","unstructured":"Hirama T, Marchand-Austin A, Ma J et al (2018) Mycobacterium xenopi genotype associated with clinical phenotype in lung disease. Lung 196:213\u2013217. \n                    https:\/\/doi.org\/10.1007\/s00408-018-0087-9","journal-title":"Lung"},{"key":"3437_CR10","doi-asserted-by":"publisher","first-page":"1702330","DOI":"10.1183\/13993003.02330-2017","volume":"51","author":"T Hirama","year":"2018","unstructured":"Hirama T, Brode SK, Beswick J et al (2018) Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic hematopoietic stem cell transplant. Eur Respir J 51:1702330. \n                    https:\/\/doi.org\/10.1183\/13993003.02330-2017","journal-title":"Eur Respir J"},{"key":"3437_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1164\/rccm.200509-1531OC","volume":"173","author":"PK Lam","year":"2006","unstructured":"Lam PK, Griffith DE, Aksamit TR et al (2006) Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 173:1283\u20131289. \n                    https:\/\/doi.org\/10.1164\/rccm.200509-1531OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3437_CR12","doi-asserted-by":"publisher","first-page":"1800170","DOI":"10.1183\/13993003.00170-2018","volume":"51","author":"J Ingen van","year":"2018","unstructured":"van Ingen J, Aksamit T, Andrejak C et al (2018) Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. Eur Respir J 51:1800170. \n                    https:\/\/doi.org\/10.1183\/13993003.00170-2018","journal-title":"Eur Respir J"},{"key":"3437_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1440-1843.2012.02277.x","volume":"18","author":"TK Marras","year":"2013","unstructured":"Marras TK, Wagnetz U, Jamieson FB, Patsios DA (2013) Chest computed tomography predicts microbiological burden and symptoms in pulmonary Mycobacterium xenopi. Respirology 18:92\u2013101. \n                    https:\/\/doi.org\/10.1111\/j.1440-1843.2012.02277.x","journal-title":"Respirology"},{"key":"3437_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.carj.2013.05.006","volume":"65","author":"MC Carrillo","year":"2014","unstructured":"Carrillo MC, Patsios D, Wagnetz U et al (2014) Comparison of the spectrum of radiologic and clinical manifestations of pulmonary disease caused by mycobacterium avium complex and mycobacterium xenopi. Can Assoc Radiol J 65:207\u2013213. \n                    https:\/\/doi.org\/10.1016\/j.carj.2013.05.006","journal-title":"Can Assoc Radiol J"},{"key":"3437_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3346\/jkms.2012.27.8.896","volume":"27","author":"SW Park","year":"2012","unstructured":"Park SW, Song JW, Shim TS et al (2012) Mycobacterial pulmonary infections in patients with idiopathic pulmonary fibrosis. J Korean Med Sci 27:896\u2013900. \n                    https:\/\/doi.org\/10.3346\/jkms.2012.27.8.896","journal-title":"J Korean Med Sci"},{"key":"3437_CR16","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jiac.2014.05.010","volume":"20","author":"K-W Jo","year":"2014","unstructured":"Jo K-W, Kim S, Lee JY et al (2014) Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy. J Infect Chemother 20:602\u2013606. \n                    https:\/\/doi.org\/10.1016\/j.jiac.2014.05.010","journal-title":"J Infect Chemother"},{"key":"3437_CR17","first-page":"1210","volume":"13","author":"RG Varadi","year":"2009","unstructured":"Varadi RG, Marras TK (2009) Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis 13:1210\u20131218","journal-title":"Int J Tuberc Lung Dis"},{"key":"3437_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1378\/chest.13-2538","volume":"146","author":"RJ Wallace","year":"2014","unstructured":"Wallace RJ, Brown-Elliott BA, McNulty S et al (2014) Macrolide\/azalide therapy for nodular\/bronchiectatic Mycobacterium avium complex lung disease. Chest 146:276\u2013282. \n                    https:\/\/doi.org\/10.1378\/chest.13-2538","journal-title":"Chest"},{"key":"3437_CR19","doi-asserted-by":"publisher","first-page":"1602503","DOI":"10.1183\/13993003.02503-2016","volume":"50","author":"W-J Koh","year":"2017","unstructured":"Koh W-J, Moon SM, Kim S-Y et al (2017) Outcomes of Mycobacterium avium complex lung disease based on clinical phenotype. Eur Respir J 50:1602503. \n                    https:\/\/doi.org\/10.1183\/13993003.02503-2016","journal-title":"Eur Respir J"},{"key":"3437_CR20","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","volume":"72","author":"CS Haworth","year":"2017","unstructured":"Haworth CS, Banks J, Capstick T et al (2017) British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax 72:ii1\u2013ii64. \n                    https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210927","journal-title":"Thorax"},{"key":"3437_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/thorax.56.3.167","volume":"56","author":"Research Committee of the British Thoracic Society","year":"2001","unstructured":"Research Committee of the British Thoracic Society (2001) First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 56:167\u2013172","journal-title":"Thorax"},{"key":"3437_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.chest.2017.04.166","volume":"152","author":"R Diel","year":"2017","unstructured":"Diel R, Ringshausen F, Richter E et al (2017) Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis. Chest 152:120\u2013142. \n                    https:\/\/doi.org\/10.1016\/j.chest.2017.04.166","journal-title":"Chest"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3437-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T19:13:04Z","timestamp":1576264384000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["3437"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3437-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2018,12,14]]},"assertion":[{"value":"2 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was reviewed by the University Health Network-Research Ethics Board (Research Ethics Board number 18-5104).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"In light of the retrospective design, the requirement of informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}